AGTC - Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q1 Fiscal Year 2022 Results - Earnings Call Transcript

Applied Genetic Technologies Corporation (AGTC) Q1 Fiscal Year Earnings Conference Call November 9, 2021, 8:00 AM ET Company Participants Sue Washer – CEO Jon Lieber – Chief Financial Officer Susan Schneider – Chief Medical Officer Conference Call Participants Joe Pantginis – H.C. Wainwright Dae Gon Ha – Stifel Yanan Zhu – Wells Fargo Zegbeh Jallah – ROTH Capital Partners Matthew Luchini – BMO Capital Markets Kristen Kluska – Cantor Fitzgerald Yun Zhong – BTIG Presentation Operator Good morning and welcome to the AGTC financial results conference call for the First Quarter of fiscal year 2022. Today's call is being recorded. Before we get started, I would like to remind everyone that during this conference call, AGTC may make forward-looking statements including statements about the Company's financial results, financial guidance, its future business strategies and operations, and its product development and regulatory progress, including statements about its ongoing and planned clinical

For further details see:

Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q1 Fiscal Year 2022 Results - Earnings Call Transcript